trending Market Intelligence /marketintelligence/en/news-insights/trending/gAOMbe5Sj_MWTQ8gQtGE6g2 content esgSubNav
In This List

Great-West Lifeco receives TSX approval for normal course issuer bid

Blog

Q&A: Data That Delivers - Automating the Credit Risk Workflow

Blog

Anticipate the Unknown Go Beyond Fundamentals to Uncover Early Signs of Private Company Credit Deterioration

Blog

Taking Loss Given Default Estimation to the Next Level: An Aspiration for All Creditors, Not Just Banks

Blog

Anticipate the Unknown A Fundamentals Approach to Detect Early Signs of Private Company Credit Deterioration


Great-West Lifeco receives TSX approval for normal course issuer bid

Great-West Lifeco Inc. received approval from the Toronto Stock Exchange for the renewal of its normal course issuer bid to purchase for cancellation up to 20 million of its common shares, equivalent to approximately 2.16% of its issued and outstanding common shares.

The normal course issuer bid will commence Jan. 22, 2020, and will expire Jan. 21, 2021. The company intends to use the normal course issuer bid to mitigate the dilutive effect of issuing securities under its stock option plan and for other capital management purposes.

Under its previous normal course issuer bid, which was terminated Jan. 17, the company purchased 2 million of its common shares at a weighted average price of C$32.90 per share for the period of Feb. 1, 2019, to Jan. 31, 2020. A non-independent trustee purchased an additional 368,883 common shares at a weighted average price of C$31.08 per share.

The 2,368,883 common shares purchased under the previous normal course issuer bid will be deducted from the 20 million common share limit of the renewed normal course issuer bid.